IRLAB Granted Additional Patent for its Drug Candidate Pirepemat Expanding the Patent Protection in the US
GOTHENBURG, SE / ACCESSWIRE / September 18, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 18, 2024 - IRLAB...